Trials / Completed
CompletedNCT00839735
Trefoil Peptides in Lung Diseases
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Bispebjerg Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The study focuses on trefoil family factor (TFF) peptides in sputum in lung diseases. The investigators hypothesize that TFF peptides are upregulated in lung diseases characterized by mucus hypersecretion.
Conditions
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2010-05-01
- Completion
- 2010-05-01
- First posted
- 2009-02-09
- Last updated
- 2021-02-17
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00839735. Inclusion in this directory is not an endorsement.